🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

12 recruiting trials

for Narcolepsy Type 2

A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH NCT07625280Phase 315 sites📍 Birmingham📍 Irvine📍 Long Beach Jazz Pharmaceuticals · Tests: Xywav, Placebo A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia NCT06752668Phase 237 sites📍 Auburn📍 Chandler📍 Scottsdale Centessa Pharmaceuticals (UK) Limited · Tests: ORX750, Placebo A Novel Approach to Manage Symptoms of Narcolepsy and Idiopathic Hypersomnia NCT07006233NA1 site📍 Macquarie Park University of Sydney · Tests: Whole Food Ketogenic Diet, Whole Food Diet Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a2 sites📍 Sioux Falls📍 Sydney Sanford Health A Study of TAK-360 in People With Narcolepsy or Idiopathic Hypersomnia NCT07646678Phase 2, Phase 324 sites📍 Chula Vista📍 Colorado Springs📍 Brandon Takeda · Tests: TAK-360, Placebo A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2 NCT07502443Phase 344 sites📍 Cullman📍 Phoenix📍 Los Angeles Alkermes, Inc. · Tests: ALKS 2680 Dose 1, ALKS 2680 Dose 2, ALKS 2680 Dose 3, Placebo Evaluation of Social Cognition in Patient With Type 1 or Type 2 Narcolepsy Versus Patients With Idiopathic Hypersomnia NCT05773872NA1 site📍 Amiens Centre Hospitalier Universitaire, Amiens · Tests: Questionary A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia NCT06767683Phase 2, Phase 350 sites📍 Cullman📍 Phoenix📍 Little Rock Alkermes, Inc. · Tests: ALKS 2680, 4mg, ALKS 2680, 6mg, ALKS 2680, 8mg, ALKS 2680, 10mg, ALKS 2680, 14mg A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2) NCT06952699Phase 252 sites📍 Auburn📍 Chandler📍 Chula Vista Takeda · Tests: TAK-360, Placebo A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence NCT07598708Phase 2, Phase 323 sites📍 Birmingham📍 Colorado Springs📍 Brandon Centessa Pharmaceuticals (UK) Limited · Tests: cleminorexton, Placebo A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia NCT07096674Phase 224 sites📍 Auburn📍 Santa Ana📍 Miami Centessa Pharmaceuticals (UK) Limited · Tests: ORX750, ORX750, ORX750 A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy NCT07493265Phase 257 sites📍 Santa Ana📍 Brandon📍 Medley Eisai Inc. · Tests: E2086, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy